Newron Pharmaceuticals Spa. NP5

XET: NP5 | ISIN: IT0004147952   12/11/2024
8,000 EUR (-3,26%)
(-3,26%)   12/11/2024
Grafiek Newron Pharmaceuticals Spa. Grafiek Newron Pharmaceuticals Spa.

Profiel Newron Pharmaceuticals Spa.

CEO: Stefan Weber

Mijn selecties